AdvocacyFeaturedPharmaStory of NFVideo Give for Treatment Options: Lilly’s Advocacy for Cutaneous Neurofibroma Treatments
Collaborations & PartnershipsCTF in the NewsFeaturedFeatured EUNF2-SWNPublicationsScience & Research From Discovery to Impact: How Collaboration Unlocked Brigatinib for NF2-Related Schwannomatosis
Collaborations & PartnershipsFeaturedFeatured EUNF2-SWNPress ReleaseScience & Research New Meningioma model in development in CTF Preclinical Hub Unlocks Opportunities for NF2-SWN Brain Tumor Therapies
FeaturedNF1PharmaStory of NFVideo Give for Tomorrow: Marcia’s Story and the Promise of More Treatments
FeaturedFeatured EUGlobalNF2-SWN Give for Hope: Rozalinda’s Challenges with NF2-SWN and Her Hope for Brigatinib
Awards & GrantsFeaturedFeatured EUNF2-SWNScience & ResearchUncategorized Young Investigator: Q&A with Isam Naber about identifying biomarkers for NF2-SWN hearing loss
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaScience & Research FDA Grants Fast Track Designation to Healx NF1 Treatment
